title: [Arterial lipiodol chemoembolization of a left liver metastasis through the right internal thoracic artery].
abstract: The purpose of this article is to illustrate the efficacy of the chemoembolization in patients with hypervascular metastases and to describe the post-embolization change in vascularization pattern. Unusual collaterals may develop following embolization. A 59-year-old woman, followed for unresectable small bowel carcinoid tumor since 1991, underwent successful chemoembolization of several liver metastases. Only one liver lesion, located in segment IV, showed interval increase in size. This lesion was supplied by the right internal mammary artery. A branch of the right internal mammary artery was catheterized using a microcatheter and embolization was performed using doxorubicine-Lipiodol (Adriblastine, Lipiodol) and gelfoam (Spongel). No complications occurred after the procedure. The right internal mammary artery should be considered as a possible source of collateral arterial supply to the liver and should be evaluated in patients with local progression of disease.
authors.affiliation: Service de Radiologie, Hôpital Ambroise Paré, Boulogne.
authors.forename: F
authors.initials: F
authors.lastname: Mignon
authors.forename: B
authors.initials: B
authors.lastname: Mesurolle
authors.forename: S D
authors.initials: SD
authors.lastname: Qanadli
authors.forename: J F
authors.initials: JF
authors.lastname: Sissakian
authors.forename: F
authors.initials: F
authors.lastname: Bruckert
authors.forename: O
authors.initials: O
authors.lastname: Barré
authors.forename: P
authors.initials: P
authors.lastname: Lacombe
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002276:Carcinoid Tumor / Q000098:blood supply / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D003097:Collateral Circulation; D003287:Contrast Media; D004317:Doxorubicin / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D005781:Gelatin Sponge, Absorbable / Q000627:therapeutic use; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D007269:Injections, Intra-Arterial; D007414:Intestinal Neoplasms / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology; D007459:Iodized Oil; D008113:Liver Neoplasms / Q000098:blood supply / Q000556:secondary* / Q000628:therapy; D008323:Mammary Arteries; D008875:Middle Aged
chemical_list: D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D003287:Contrast Media; D006490:Hemostatics; D007459:Iodized Oil; D004317:Doxorubicin